We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AACI
376
DELISTED
Armada Acquisition Corp. I Common Stock
AACI
$197K 0.01%
+19,436
New +$194K
GXIIU
377
DELISTED
GX Acquisition Corp. II Unit
GXIIU
$194K 0.01%
19,247
PLMIU
378
DELISTED
Plum Acquisition Corp. I Units
PLMIU
$193K 0.01%
19,172
POWRU
379
DELISTED
Powered Brands Units
POWRU
$193K 0.01%
19,176
+1,688
+10% +$16.9K
BNIX
380
DELISTED
Bannix Acquisition Corp. Common Stock
BNIX
$176K ﹤0.01%
17,322
+6,122
+55% +$61.7K
MSDAU
381
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$171K ﹤0.01%
16,951
+14,093
+493% +$141K
FLYX icon
382
flyExclusive
FLYX
$62.1M
$170K ﹤0.01%
+17,026
New +$168K
ARIZU
383
DELISTED
Arisz Acquisition Corp. Unit
ARIZU
$152K ﹤0.01%
+15,000
New +$151K
FSNB.U
384
DELISTED
Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
FSNB.U
$150K ﹤0.01%
+14,910
New +$148K
LITT
385
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$149K ﹤0.01%
+14,991
New +$148K
LATGU
386
DELISTED
Chenghe Acquisition I Co. Unit
LATGU
$148K ﹤0.01%
14,400
+4,400
+44% +$44.9K
ICNC.U
387
DELISTED
Iconic Sports Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
ICNC.U
$147K ﹤0.01%
+14,100
New +$144K
KSI
388
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$147K ﹤0.01%
14,661
-15,568
-52% -$155K
BLNG
389
DELISTED
Belong Acquisition Corp. Class A Common Stock
BLNG
$142K ﹤0.01%
14,329
+4,280
+43% +$42.7K
VSAC
390
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$139K ﹤0.01%
13,506
+2,000
+17% +$20.3K
MNTN
391
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$139K ﹤0.01%
13,587
-2,800
-17% -$28.4K
LBBB
392
DELISTED
Lakeshore Acquisition II Corp. Ordinary Shares
LBBB
$138K ﹤0.01%
+13,570
New +$137K
FGMC
393
DELISTED
FG Merger Corp. Common Stock
FGMC
$138K ﹤0.01%
13,558
+903
+7% +$9.13K
ARRWU
394
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
$136K ﹤0.01%
13,552
NGC
395
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$136K ﹤0.01%
13,537
+1,107
+9% +$11K
INTEU
396
DELISTED
Integral Acquisition Corporation 1 Unit
INTEU
$135K ﹤0.01%
+13,335
New +$134K
PPYAU
397
DELISTED
Papaya Growth Opportunity Corp. I Unit
PPYAU
$132K ﹤0.01%
12,906
+300
+2% +$3.03K
BRIV
398
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$131K ﹤0.01%
+13,108
New +$129K
ITAQU
399
DELISTED
Industrial Tech Acquisitions II, Inc. Unit
ITAQU
$130K ﹤0.01%
+12,800
New +$129K
HORIU
400
DELISTED
Emerging Markets Horizon Corp. Unit
HORIU
$128K ﹤0.01%
12,544
+9,400
+299% +$95.7K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.